Also, we had briefed the challenges involved in developing therapeutic peptides and the global market potential for peptide therapeutics.doi:10.1007/s10989-017-9650-0Nagarajan, KrishnanandMarimuthu, Sathish KumarPalanisamy, SelvamaniSubbiah, Latha
announces that Deborah O’Neil, Ph.D., Chief Executive Officer of NovaBiotics, delivered a presentation highlighting NovaBiotics’ novel peptide drug candidates at the Peptide Therapeutics Forum 2021 that took place August 19-20, 2...
The gonadotropin-releasing hormone plays a key role in reproduction. Lecirelin is a nonapeptide analogue of GnRH that is used to stimulate ovulation in cow
The industry's most renowned event to accelerate oligo, peptide, and mRNA/vaccine therapeutics to market: Leading strategies for expediting R&D & improving CMC efficiency.
11 - 13 Nov 2025 CONNECT WITH THE INDUSTRY ANYWHERE IN THE WORLD Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.We have both physical or ...
Table 3 encompasses novel therapeutics that target Aβ pathology and are detailed below. Table 3. Therapeutic strategies targeting Aβ peptide in clinical trials. Table 2 was created with the help of ClinicalTrials.gov., Alzforum and recent reviews on AD treatment (Cummings et al., 2020, ...
In addition to antifungal activity, biocompatibility with host cells is a key parameter for the clinical application of therapeutics. To test the biocompatibility of our ternary polymers with different charged groups, we evaluated their capability of lysing sheep RBCs by measuring the hemolytic concentrat...
Racial and ethnic disparities in health outcomes are largely attributable to the pervasiveness of structural racism, and patients who are marginalized by racism have less access to novel therapeutics. Objectives To evaluate GLP-1 RA uptake among a commercially insured population of patients with T2D; ...
In recent years, the occurrence of a wide variety of drug-resistant diseases has led to an increase in interest in alternate therapies. Peptide-based drugs
Recently, the prolonged delivery of therapeutics has resulted in the development of polymeric long-acting injectables as an alternative to conventional oral delivery systems. These advanced drug delivery systems have shown promising results in improving pharmacokinetic profiles and different physiochemical char...